paclitaxel/carboplatin/lapatinib
BR07/29/10
Phase 2 small_molecule active
Quick answer
paclitaxel/carboplatin/lapatinib for ErbB2-Positive Stage I-III Breast Cancer is a Phase 2 program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hospital Authority, Hong Kong
- Indication
- ErbB2-Positive Stage I-III Breast Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active